HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice.

Abstract
Oxidative stress is implicated as an important mechanism by which diabetes causes nephropathy. Astaxanthin, which is found as a common pigment in algae, fish, and birds, is a carotenoid with significant potential for antioxidative activity. In this study, we examined whether chronic administration of astaxanthin could prevent the progression of diabetic nephropathy induced by oxidative stress in mice. We used female db/db mice, a rodent model of type 2 diabetes, and their non-diabetic db/m littermates. The mice were divided into three groups as follows: non-diabetic db/m, diabetic db/db, and diabetic db/db treated with astaxanthin. Blood glucose level, body weight, urinary albumin, and urinary 8-hydroxydeoxyguanosine (8-OHdG) were measured during the experiments. Histological and 8-OHdG immunohistochemical studies were performed for 12 weeks from the beginning of treatment. After 12 weeks of treatment, the astaxanthin-treated group showed a lower level of blood glucose compared with the non-treated db/db group; however, both groups had a significantly high level compared with the db/m mice. The relative mesangial area calculated by the mesangial area/total glomerular area ratio was significantly ameliorated in the astaxanthin-treated group compared with the non-treated db/db group. The increases in urinary albumin and 8-OHdG at 12 weeks of treatment were significantly inhibited by chronic treatment with astaxanthin. The 8-OHdG immunoreactive cells in glomeruli of non-treated db/db mice were more numerous than in the astaxanthin-treated db/db mice. In this study, treatment with astaxanthin ameliorated the progression and acceleration of diabetic nephropathy in the rodent model of type 2 diabetes. The results suggested that the antioxidative activity of astaxanthin reduced the oxidative stress on the kidneys and prevented renal cell damage. In conclusion, administration of astaxanthin might be a novel approach for the prevention of diabetes nephropathy.
AuthorsYuji Naito, Kazuhiko Uchiyama, Wataru Aoi, Goji Hasegawa, Naoto Nakamura, Norimasa Yoshida, Takashi Maoka, Jiro Takahashi, Toshikazu Yoshikawa
JournalBioFactors (Oxford, England) (Biofactors) Vol. 20 Issue 1 Pg. 49-59 ( 2004) ISSN: 0951-6433 [Print] Netherlands
PMID15096660 (Publication Type: Journal Article)
Chemical References
  • Xanthophylls
  • beta Carotene
  • 8-Hydroxy-2'-Deoxyguanosine
  • astaxanthine
  • Deoxyguanosine
Topics
  • 8-Hydroxy-2'-Deoxyguanosine
  • Albuminuria
  • Animals
  • Deoxyguanosine (analogs & derivatives, urine)
  • Diabetes Mellitus, Type 2 (physiopathology)
  • Diabetic Nephropathies (pathology, prevention & control)
  • Disease Models, Animal
  • Female
  • Kidney (pathology)
  • Mice
  • Mice, Mutant Strains
  • Reference Values
  • Regression Analysis
  • Tissue Distribution
  • Xanthophylls
  • beta Carotene (analogs & derivatives, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: